Valsartan

This classification denotes an angiotensin ii receptor antagonist with the molecular formula C24H29N5O3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 80M03YXJ7I, chemically known as l-valine, n-(1-oxopentyl)-n-((2-(1h-tetrazol-5-yl)(1,1-biphenyl)-4-yl)methyl)- but generally known as valsartan, which bears US NIH Compound Identifier 60846. European Medicines Agency schedules Valsartan in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB00017MIG. The term VALSARTAN is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 7, No3, 1993, List 33). World Health Organization schedules valsartan in its Anatomical Therapeutic Chemical (ATC) Classification. VALSARTAN is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule valsartan under HS 29339990 and SITC 51577. As of Q4 2014, VALSARTAN remains the US FDA Preferred Term for this commodity. Valsartan bears US NLM identifiers UMLS ID C0216784 and NCI Concept Code C47781. SMILES: OC(=O)C(N(Cc1ccc(cc1)c1c(cccc1)c1n[nH]nn1)C(=O)CCCC)C(C)C.